Edition:
United Kingdom

Global blood Therapeutics reports approval of voxelotor as nonproprietary name for GBT440


Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - Global Blood Therapeutics Inc ::Global Blood Therapeutics announces approval of first-in-class “voxelotor” as nonproprietary name for gbt440.Global Blood Therapeutics Inc - ‍world Health Organization has approved "voxelotor" as international nonproprietary name for gbt440​.